Evan Castiglia Overview
- Firm
- Thuja Capital Ma...
- Primary Position
-
Investment Direc...
- Primary Industry
-
Healthcare
- Active Board Seats
-
4
- Med. Deal Size
-
Evan Castiglia General Information
Biography
Mr. Evan Castiglia serves as Investment Director & Partner at Thuja Capital Management. He serves as a Board of Directors at Tacalyx. He serves as a Board Member at AstriVax and InnoSIGN. He also served as a Board member at Carevive and Gradient Denervation Technologies. He served as Principal of venture Investments at Philips Health Technology Venture Fund. He served as a Board Member at Siilo. Previously, he served as Chief Business Officer at RareCyte. Before RareCyte, he was a portfolio manager for Isis Innovation Ltd. His efforts focused on leading numerous technology commercialization and intellectual property projects based on cutting-edge academic research. Before his time at Oxford, he was the Director of Business Development at the Institute for Systems Medicine Planning Authority in Washington State. He earned his bachelor's degree from Gonzaga University and his MBA from the University of Oxford. He served as a Venture Partner and Joyance Partner at Social Starts.
Contact Information
Address
- LSI Buidling
- Yalelaan 62
- 3584 CM Utrecht
- Netherlands
Evan Castiglia Positions (1)
| Firm name | Firm type | Title | Location | Industry | Since |
|---|---|---|---|---|---|
| Thuja Capital Management | Investor | Investment Director & Partner | Utrecht, Netherlands | Venture Capital |
Evan Castiglia Board Seats (4)
| Company | Industry | Ownership Status | Financing Status | Location | Since |
|---|---|---|---|---|---|
| AstriVax | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | Leuven, Belgium | |
| Gradient Denervation Technologies | Other Devices and Supplies | Privately Held (backing) | Venture Capital-Backed | Suresnes, France | |
| InnoSIGN | Biotechnology | Privately Held (backing) | Venture Capital-Backed | Eindhoven, Netherlands | |
| Tacalyx | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | Berlin, Germany |
Evan Castiglia Lead Partner on Deals (3)
Evan Castiglia has been the lead partner on 3 deals. Their latest deal was with Tacalyx, a drug discovery company. The deal was made for on 11-Jun-2024.
| Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
|---|---|---|---|---|---|---|
| Tacalyx | 11-Jun-2024 | Seed Round | Completed | Drug Discovery | Berlin, Germany | |
| Gradient Denervation Technologies | 26-Jul-2023 | Completed | Other Devices and Supplies | Suresnes, France | ||
| Carevive | 11-May-2022 | Completed | Outcome Management (Healthcare) | South Jordan, UT |
Evan Castiglia Network (79)
Board Members (45)
| Name | Company | Representing | Location | From |
|---|---|---|---|---|
| Lukas Guenther MD | Gradient Denervation Technologies | Self | Suresnes, France | |
| Vera Mehler Ph.D | Tacalyx | Coparion | Berlin, Germany | |
| Tacalyx | Tacalyx | Berlin, Germany | ||
| AstriVax | Korys Investments | Leuven, Belgium | ||
| Tacalyx | Boehringer Ingelheim Venture Fund | Berlin, Germany |
Portfolio Executives (29)
| Name | Company | Role | Deal date | Location |
|---|---|---|---|---|
| Kajo Wiest | Tacalyx | Head of Finance & Administration | 11-Jun-2024 | Berlin, Germany |
| Peter Sondermann Ph.D | Tacalyx | Co-Founder, Chief Executive Officer & Managing Director | 11-Jun-2024 | Berlin, Germany |
| Tacalyx | Co-Founder & Board Member | 11-Jun-2024 | Berlin, Germany | |
| Tacalyx | Co-Founder | 11-Jun-2024 | Berlin, Germany | |
| Gradient Denervation Technologies | Chief Financial Officer | 26-Jul-2023 | Suresnes, France |
Fund Team Members (5)
| Name | Investor | Fund | Fund Location |
|---|---|---|---|
| Tyler Hayes MD | Thuja Capital Management | Thuja Capital Healthcare Fund III | Utrecht, Netherlands |
| Michel Briejer Ph.D | Thuja Capital Management | Thuja Capital Healthcare Fund III | Utrecht, Netherlands |
| Thuja Capital Management | Utrecht, Netherlands | ||
| Thuja Capital Management | Utrecht, Netherlands | ||
| Thuja Capital Management | Utrecht, Netherlands |
Evan Castiglia Affiliated Funds (1)
| Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
|---|---|---|---|---|---|---|---|---|
| Thuja Capital Healthcare Fund III | Thuja Capital Management | Venture Capital - Early Stage | Closed | 2020 |
Evan Castiglia FAQs
-
Who is Evan Castiglia?
Mr. Evan Castiglia serves as Investment Director & Partner at Thuja Capital Management.
-
How much does Evan Castiglia typically invest?
Evan Castiglia's median deal size is .
-
What is Evan Castiglia’s main position?
Evan Castiglia’s primary position is Investment Director & Partner.
-
How many active board seats does Evan Castiglia hold?
Evan Castiglia holds 4 board seats including AstriVax, Gradient Denervation Technologies, InnoSIGN, and Tacalyx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
